CS logo
small CS logo
Chu Sart Tilman; Medical Oncology

Liege, Belgium
Universitair medisch centrum in Luik

About Chu Sart Tilman; Medical Oncology


Het Academisch Ziekenhuis van Luik is een ziekenhuis in de Belgische stad Luik. Het ziekenhuis is een academisch ziekenhuis verbonden aan de Université de Liège. Naast de hoofdcampus in Sart-Tilman waar 625 bedden zijn erkend heeft het ziekenhuis ook campussen of afdelingen in Chênée, Esneux en Fraiture-en-Condroz.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Chu Sart Tilman; Medical Oncology


During the past decade, Chu Sart Tilman; Medical Oncology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Chu Sart Tilman; Medical Oncology" #1 collaborator was "Breast International Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Chu Sart Tilman; Medical Oncology


According to Clinical.Site data, the most researched conditions in "Chu Sart Tilman; Medical Oncology" are "Early Breast Cancer" (1 trials) and "Metastatic Breastcancer" (1 trials). Many other conditions were trialed in "Chu Sart Tilman; Medical Oncology" in a lesser frequency.

Clinical Trials Intervention Types at Chu Sart Tilman; Medical Oncology


Most popular intervention types in "Chu Sart Tilman; Medical Oncology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Endocrine Therapy of Physician's Choice" (1 trials), "Giredestrant" (1 trials), "LHRH Agonist" (1 trials) and "nab-Paclitaxel" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Chu Sart Tilman; Medical Oncology


The vast majority of trials in "Chu Sart Tilman; Medical Oncology" are 1 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Chu Sart Tilman; Medical Oncology


Currently, there are NaN active trials in "Chu Sart Tilman; Medical Oncology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Chu Sart Tilman; Medical Oncology, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Chu Sart Tilman; Medical Oncology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".